Yoshimura, Reiji <br/><br/>
Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients.  [electronic resource] 

 -  Progress in neuro-psychopharmacology & biological psychiatry  Jun 2007 
 - 1072-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0278-5846 
<br/><br/><label>Standard No.: </label>10.1016/j.pnpbp.2007.03.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antipsychotic Agents--blood<br/>Brain-Derived Neurotrophic Factor--blood<br/>Catecholamines--metabolism<br/>Chromatography, High Pressure Liquid<br/>Female<br/>Genotype<br/>Humans<br/>Immunoenzyme Techniques<br/>Isoxazoles--blood<br/>Male<br/>Methoxyhydroxyphenylglycol--blood<br/>Middle Aged<br/>Norepinephrine Plasma Membrane Transport Proteins--blood<br/>Paliperidone Palmitate<br/>Polymorphism, Genetic<br/>Pyrimidines--blood<br/>Risperidone--blood<br/>Schizophrenia--blood